This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Sep 1;140(9):933-935.

doi: 10.1182/blood.2022017284.

A virtuosic CADENZA played by sutimlimab

Satheesh Chonat^{1

2}, Sean R Stowell³

Affiliations

Affiliations

¹ Children's Healthcare of Atlanta.
² Emory University School of Medicine; and.
³ Harvard Medical School.

PMID: 36048476
DOI: 10.1182/blood.2022017284

Free article

Editorial

A virtuosic CADENZA played by sutimlimab

Satheesh Chonat et al. Blood. 2022.

Free article

. 2022 Sep 1;140(9):933-935.

doi: 10.1182/blood.2022017284.

Authors

Satheesh Chonat^{1

2}, Sean R Stowell³

Affiliations

¹ Children's Healthcare of Atlanta.
² Emory University School of Medicine; and.
³ Harvard Medical School.

PMID: 36048476
DOI: 10.1182/blood.2022017284

No abstract available

PubMed Disclaimer

Comment on

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
Röth A, Berentsen S, Barcellini W, D'Sa S, Jilma B, Michel M, Weitz IC, Yamaguchi M, Nishimura JI, Vos JMI, Storek M, Wong N, Patel P, Jiang X, Vagge DS, Wardęcki M, Shafer F, Lee M, Broome CM. Röth A, et al. Blood. 2022 Sep 1;140(9):980-991. doi: 10.1182/blood.2021014955. Blood. 2022. PMID: 35687757 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems